We are live on
!
Find out more
CCG
Chatham Capital Group Portfolio holdings
AUM
$783M
1-Year Est. Return
31.99%
This Fund
S&P 500
This Quarter
Est. Return
-14.6%
1 Year Est. Return
+31.99%
3 Year Est. Return
+89.87%
5 Year Est. Return
+115.31%
10 Year Est. Return
+283.24%
AUM
$339M
AUM Growth
-$66.8M
(-16%)
Cap. Flow
+$5.1M
Cap. Flow
% of AUM
1.5%
Top 10 Holdings %
Top 10 Hldgs %
33.48%
Holding
171
New
12
Increased
34
Reduced
77
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Express
AXP
|
+$4.42M |
| 2 |
Comcast
CMCSA
|
+$3.65M |
| 3 |
Microsoft
MSFT
|
+$3.46M |
| 4 |
Intel
INTC
|
+$3.27M |
| 5 |
Nike
NKE
|
+$3.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$3.96M |
| 2 |
Bank of America
BAC
|
+$3.72M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$2.11M |
| 4 |
West Pharmaceutical
WST
|
+$1.94M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$1.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.21% |
| 2 | Healthcare | 8.41% |
| 3 | Financials | 7.57% |
| 4 | Industrials | 6.45% |
| 5 | Consumer Discretionary | 5.16% |
Similar funds
NCM
MO
TIS
QCMNJ
GA
TCMX
RTM
SG
Chatham Capital Group's Q1 2020 Portfolio in Review
As of Q1 2020, Chatham Capital Group held 171 positions worth $339M, down 16% from $406M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Chatham Capital Group's Q1 2020 filing shows 12 new, 34 increased, 77 reduced and 15 closed positions. Its largest new stake was American Express: 37,950 shares worth $3.25M. The largest sale was State Street SPDR S&P Biotech ETF, an estimated $3.96M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Financials.
- Chatham Capital Group's largest Q1 2020 buy was American Express: 37,950 shares worth $3.25M.
- Chatham Capital Group added most to Microsoft in Q1 2020, an estimated $3.46M increase.
- Chatham Capital Group's biggest Q1 2020 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $3.96M.
- Chatham Capital Group fully exited West Pharmaceutical in Q1 2020, selling an estimated $1.94M.
- Chatham Capital Group's ten largest holdings make up 33% of its $339M portfolio in Q1 2020.
- Chatham Capital Group opened 12 new positions and closed 15 in Q1 2020.
- Chatham Capital Group's portfolio value fell 16% quarter-over-quarter to $339M.
Based on Chatham Capital Group's 13F filing for Q1 2020, filed 1 May 2020.